640 filings
Page 7 of 32
DEFA14A
x83alpuegsdph
20 Nov 20
Additional proxy soliciting materials
11:11am
DEFA14A
uveqdi1
20 Nov 20
Additional proxy soliciting materials
12:00am
DEFA14A
silcf4fk49
19 Nov 20
Additional proxy soliciting materials
4:48pm
8-K
z46n sxy7
19 Nov 20
Ziopharm Oncology Appoints Mary Thistle to Board of Directors
4:46pm
DFAN14A
boi6m
19 Nov 20
Additional proxy materials by non-management
4:14pm
DFAN14A
ayrodjsap3
18 Nov 20
Additional proxy materials by non-management
5:16pm
DFAN14A
d6imlrov92ckw
16 Nov 20
Additional proxy materials by non-management
2:48pm
DFAN14A
g4cydeakj3 irg5a2
13 Nov 20
Additional proxy materials by non-management
4:56pm
DFAN14A
6tsepnt 8x9sb4edh
12 Nov 20
Additional proxy materials by non-management
3:07pm
DFAN14A
8hc4atsk0bwey63f
5 Nov 20
Additional proxy materials by non-management
5:15pm
8-K
nx1s7k59n8u7 ay
5 Nov 20
Ziopharm Oncology Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:07pm
DFRN14A
38w3jdggat ba2n
4 Nov 20
Revised proxy by non-management
4:09pm
DEFA14A
3yjm2kkugg3sg
2 Nov 20
Additional proxy soliciting materials
5:17pm
DFAN14A
2hcggengsragijvufh
2 Nov 20
Additional proxy materials by non-management
4:03pm
DEFA14A
wb3n2fu67lxgx
2 Nov 20
Additional proxy soliciting materials
9:18am
DEFA14A
xfavm
2 Nov 20
Additional proxy soliciting materials
9:15am
DEFC14A
00pdj6
2 Nov 20
Proxy in contested solicitation
8:34am
DEFC14A
xff2l4n 22no
30 Oct 20
Proxy in contested solicitation
4:46pm
PRRN14A
1nsm8
29 Oct 20
Revised preliminary proxy statement filed by non-management
4:48pm